Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Cigna    CI

CIGNA (CI)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Cigna To Buy Great American Supplemental Benefits For $295 Million

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/11/2012 | 12:28am CEST

Cigna Corp. (>> CIGNA Corporation) has agreed to acquire American Financial Group Inc.'s (AFG) Medicare supplement and critical-illness businesses for approximately $295 million in cash, as the managed-care company looks to expand its presence in the individual and seniors markets.

Cigna said its acquisition of Great American Supplemental Benefits Group, one of the largest manufacturers of supplemental health insurance products in the U.S., is expected to close in the second half of 2012.

Great American generated approximately $325 million of revenue last year.

Cigna said the acquisition will expand its individual supplemental offerings to customers in the U.S., bring scaled offerings to the seniors market and extend its direct-to-consumer retail channel.

The deal comes after Cigna bought Medicare carrier HealthSpring Inc. in January for $3.8 billion. The HealthSpring acquisition represented a change in the balance of Cigna, which had primarily focused on employers but will now also be a major source of both Medicare prescription-drug plans and Medicare Advantage coverage, the private insurers' version of the government program.

Cigna has seen its revenue grow in recent quarters, helped by growing membership and a continuing trend of patients using fewer health-care services amid a shaky economy. Last week, the company reported its first-quarter earnings fell 10%, due in part to acquisition costs, though membership growth contributed to better-than-expected revenue.

Meanwhile, American Financial said the deal is expected to be slightly dilutive to its earnings in the short term but will help the company focus on its core businesses.

Cigna shares were up by 11 cents to $45.02 after hours. The stock is up 6.9% so far this year.

-By Nathalie Tadena, Dow Jones Newswires; 212-416-3287; [email protected]

Stocks mentioned in the article : CIGNA Corporation
Stocks mentioned in the article
ChangeLast1st jan.
AMERICAN FINANCIAL GROUP INC 0.27% 114.14 Delayed Quote.5.73%
CIGNA 0.24% 171.7 Delayed Quote.-15.14%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CIGNA
04/25CIGNA FOUNDATION : Gives Grant to Broward County Education Foundation
BU
04/25CIGNA CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8..
AQ
04/24CIGNA CORPORATION (NYSE : CI) Files An 8-K Other Events
AQ
04/23CIGNA CORP : Other Events (form 8-K)
AQ
04/17UnitedHealth earnings ease investor worries over flu season, stock up
RE
04/12CIGNA CORP : Entry into a Material Definitive Agreement, Creation of a Direct Fi..
AQ
04/05CIGNA : Partnership with Physicians Successfully Reduces Opioid Use by 25 Percen..
AQ
04/05CIGNA CORPORATION : ’s First Quarter 2018 Earnings Release Details
BU
04/05CIGNA : America’s Favorite TV Doctors of America Are Now On-Call
BU
04/04GLANCY PRONGAY & MURRAY LLP : Announces Investigation on Behalf of Cigna Corpora..
BU
More news
News from SeekingAlpha
04/17Fixing Drug Costs 
04/16Health insurers/managed care firms up ahead of UNH Q1 earnings tomorrow 
04/12EXPRESS SCRIPTS : Heads (Cigna Buyout) Or Tails (Go Solo), Investors Can Win Eit.. 
04/08HEALTHCARE : Eating You Alive 
04/06Blue Cross Blue Shield Insurers may be afoul of antitrust law 
Financials ($)
Sales 2018 44 361 M
EBIT 2018 4 054 M
Net income 2018 2 923 M
Debt 2018 3 400 M
Yield 2018 0,03%
P/E ratio 2018 14,18
P/E ratio 2019 12,43
EV / Sales 2018 1,02x
EV / Sales 2019 0,80x
Capitalization 41 854 M
Chart CIGNA
Duration : Period :
Cigna Technical Analysis Chart | CI | US1255091092 | 4-Traders
Technical analysis trends CIGNA
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 216 $
Spread / Average Target 26%
EPS Revisions
Managers
NameTitle
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Eric Palmer Chief Financial Officer & Executive Vice President
Alan M. Muney Chief Medical Officer
Mark L. Boxer Global Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA-15.14%41 854
UNITEDHEALTH GROUP6.30%226 762
ANTHEM INC0.00%58 129
AETNA-1.77%57 936
HUMANA18.72%40 548
CENTENE CORPORATION6.80%19 351